| Catalog Code: | NB110-39048 |
| Product Type: | Primary Antibody |
| Product Name: | FLT3 Antibody |
| List Price: | 325 |
| Clonality: | Polyclonal |
| Gene ID: | 2322 |
| Host: | Rabbit |
| Product Description: | Rabbit Polyclonal anti-FLT3 |
| Cross Reactivity: | Human. Other species not tested. |
| Species Summary: | Hu |
| Background: | FLT3, a PDGF Receptor-type protein kinase, promotes the differentiation and proliferation of hematopoietic cells by binding to hematopoietic growth factor. Mutations of the FLT3 gene have been implicated in acute myeloid leukemia. |
| Alternate Names: | anti-FMS-Related Tyrosine Kinase 3 antibody |
| Immunogen: | Synthetic peptide (exact sequence is proprietary information). |
| Epitope: | internal domain of human |
| Specificity: | This antibody is specific to the human FLT3 protein. |
| Purity: | peptide affinity purified |
| Buffer: | Phosphate buffered saline, PH 7.7 |
| Packaging: | 0.05 mg peptide affinity purified Rabbit antisera. |
| Package Size: | 0.05 mg |
| Concentration: | 1 mg/ml |
| Uses: | This antibody is useful for immunohistochemistry. Optimal dilution to be determined by the researcher. |
| Application Summary: | IHC |
| General References: | 1. Gilliland DG. FLT3 Inhibitors in the Treatment of AML. Clin Adv Hematol Oncol (2):708-10 (2004 Nov) 2. Chen W, Jones D, Medeiros LJ, Luthra R, and Lin P. Acute myeloid leukaemia with FLT3 gene mutations of both internal tandem duplication and point m |